Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...

Samsara is the IBD Stock of the Day ahead of its Q4 earnings report due March 6. Samara stock has forged a cup base, rebounding from a sell-off.

The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...

A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively ...

The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...

Ulcerative Colitis UC is a chronic inflammatory bowel disease that can lead to frequent bloating Read on to learn its causes ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...

Brady Cl A saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 72. Please watch the ...

In terms of fundamentals, Omnicell has posted three quarters of increasing earnings growth. Revenue growth has also moved ...

The activist investor plans to push the oil refiner to consider selling or spinning off its energy-transportation business.

Jordan’s King Abdullah II is set to meet with President Trump at the White House as the president aims sell him on his plan to resettle Gaza.